GLOBUS MEDICAL, INC. (GMED) Free cash flow 2016–2025
GLOBUS MEDICAL, INC. (GMED) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$588.8MFY2025 · since FY2016: $106.9M → $588.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $588.8M | +45.3% |
| FY2024 | $405.2M | +145.2% |
| FY2023 | $165.2M | +58.2% |
| FY2022 | $104.4M | -52.4% |
| FY2021 | $219.4M | +62.3% |
| FY2020 | $135.1M | +33.5% |
| FY2019 | $101.2M | -17.0% |
| FY2018 | $121.9M | +13.2% |
| FY2017 | $107.8M | +0.8% |
| FY2016 | $106.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice